In previous studies, we found higher levels of CD59 expression in bone metastases of patients with prostate cancer than in primary prostate cancer lesions, suggesting that CD59 may play an important role in the metastasis of prostate cancer to the bone. This evidence concerns the gene CD59 and prostate cancer.